CD133‐expressing cancer cells with a stem cell‐like phenotype are responsible for tumor recurrence.29 CD133 is also a common marker of stemness and expressed by normal tissue‐resident and hematopoietic stem cells; however, it is no longer detectable after differentiation. This evidence concerns the gene PROM1 and neoplasm.